Brand loyalty, generic entry and price competition in pharmaceuticals in the quarter century after the 1984 Waxman-Hatch legislation
Year of publication: |
2011
|
---|---|
Authors: | Berndt, Ernst R. ; Aitken, Murray L. |
Published in: |
International journal of the economics of business. - Abingdon, Oxfordshire : Routledge, ISSN 1357-1516, ZDB-ID 1196953-2. - Vol. 18.2011, 2, p. 177-201
|
Subject: | Pharmaindustrie | Pharmaceutical industry | Generika | Generic drugs | Markenführung | Brand management | Preis | Price | Wettbewerb | Competition | Konsumentenverhalten | Consumer behaviour | Markentreue | Brand loyalty | USA | United States | 1984-2009 |
-
Berndt, Ernst R., (2010)
-
Berndt, Ernst R., (2014)
-
Berndt, Ernst R., (2010)
- More ...
-
Measuring and Modeling Health Care Costs
Abraham, Jean M., (2018)
-
Berndt, Ernst R., (2010)
-
Characterizing markets for biopharmaceutical innovations : do biologics differ from small molecules?
Trusheim, Mark, (2010)
- More ...